Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Polaris Dawn Selects 38 Science and Research Experiments to Advance Human Health and Space Exploration

This image opens in the lightbox

News provided by

Polaris Dawn

24 Oct, 2022, 11:01 GMT

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, Oct. 24, 2022 /PRNewswire/ -- Polaris Dawn, the first of the Polaris Program's three human spaceflight missions, announced today the extensive suite of science and research experiments the crew and SpaceX will conduct throughout the mission. The selected projects are designed to advance both human health on Earth and on future long-duration spaceflights.

"The mission profile of Polaris Dawn affords us some great opportunities to expand our collective knowledge about the human body in space and associated applicability here on Earth. Our science and research agenda will enhance the body of knowledge for future long-duration spaceflight which will take us back to the Moon and on to Mars; as well as progress our knowledge and understanding for humankind here on Earth. The Polaris Dawn team along with the exceptional science and research team at SpaceX cast a wide net to find the best experiments to fly with us. We greatly appreciate all of the submissions and enormous support of the work. Polaris Dawn is the first mission in the Polaris Program and our goal is to continue to find the best research out there for our future spaceflights," stated Jared Isaacman, mission commander.

SpaceX is targeting no earlier than March 2023 for Falcon 9's launch of the Polaris Dawn mission from Launch Complex 39A at NASA's Kennedy Space Center in Florida. Over the course of five days, Dragon and the Polaris Dawn crew will endeavor to travel to 1,400 km – the highest Earth orbit ever flown – and attempt the first-ever commercial spacewalk. Many of the selected research projects take advantage of this unique mission profile, including the relatively high-radiation levels due to the high-altitude orbit and exposure to hard-vacuum during the spacewalk. Such projects include but are not limited to:

  • Use of ultrasound to measure changes to the eye's structure in microgravity; track organ blood flow patterns to monitor nutrient absorption, toxin filtration, and blood clot prevention; and to test innovative just-in-time training modules to allow successful use of this tool without extensive training.
  • Wearing a contact lens embedded with microelectronics that will allow the crew to continuously monitor changes in the shape and pressure of the eye, a first for a human spaceflight mission. Collected data will contribute to the understanding of spaceflight associated Spaceflight Associated Neuro-Ocular Syndrome (SANS), a condition that can cause degraded vision and poses a risk for human performance during a mission.
  • Investigating the effects of microgravity, magnetic, and fungal influences on root growth of low-Earth orbit germinating plants to help inform plant growth procedures for food viability and sustainability in lunar or Martian gravitational environments as well as deep-space exploration. Additionally, the research will provide actionable physical and genetic data relative to plant growth utilizing gravitropism, fungal volatiles, and magnetic fields to improve food production here on Earth.
  • Determining how the body processes common pharmaceuticals in orbit to continue testing theoretical evidence that space changes the efficacy and potential safety of these drugs. The effects of spaceflight on the stability of pharmaceuticals will also be evaluated;
  • Expanding on-orbit medical capabilities, including the development of cardiopulmonary resuscitation (CPR) procedures for use in the Dragon spacecraft, and demonstrating the use of a fiberoptic camera to image and better understand how spaceflight fluid shifts may affect airway management in a medical emergency;
  • Brain mapping via a portable MRI within hours of splashdown, giving unique insight into how the brain is affected by microgravity and how it readapts, contributing to studies of the brain's involvement in Spaceflight Associated Neuro-Ocular Syndrome (SANS);
  • Validation of a continuous glucose monitoring device to increase access to space for a more diverse population of future astronauts; and
  • Measurement of the high-energy neutron radiation environment to which the crew will be exposed to help inform and improve space radiation exposure prediction models.

Polaris Dawn and SpaceX will collaborate with 23 institutions on the selected experiments, such as the Translational Research Institute for Space Health (TRISH), University of Texas, Houston, University of Augusta, University of Colorado Boulder, Baylor College of Medicine, Medical University of South Carolina, Pacific Northwest National Laboratory, Weill Cornell Medicine, Johns Hopkins University Applied Physics Laboratory, and the U.S. Air Force Academy. For a full list and description of the selected science & research experiments and associated institutions, visit Polaris Dawn's Science and Research site. While each experiment was selected for inclusion in the mission profile, additional testing and qualification requirements are underway. A final list of approved-to-fly experiments will be published closer to launch.

Media Contacts:
Sarah Grover
Communications Director for the Polaris Program
media@polarisprogram.com 

About the Polaris Program and Polaris Dawn
The Polaris Program is a first-of-its-kind effort to rapidly advance human spaceflight capabilities while continuing to raise funds and awareness for important causes here on Earth. The program will consist of up to three human spaceflight missions that will demonstrate new technologies, conduct extensive research, and ultimately culminate in the first flight of SpaceX's Starship with humans on board. All missions will be commanded by Jared Isaacman, an accomplished pilot and astronaut who lead Inspiration4, the world's first all-civilian mission to orbit that helped raise over $240 million for St. Jude Children's Research Hospital®.

Polaris Dawn is an important first mission as part of this effort, continuing to raise awareness and money for St. Jude in addition to advancing healthcare access and connectivity to disconnected communities around the world. Polaris Dawn endeavors to reach the highest Earth orbit ever flown, attempt the first-ever commercial spacewalk, conduct extensive research to further our understanding of human health on Earth and during future long-duration spaceflights, and test Starlink's laser-based communications in space.

To learn more about the Polaris Program, visit www.PolarisProgram.com and follow along on Twitter (@PolarisProgram) and Instagram (@PolarisProgram).

Logo - https://mma.prnewswire.com/media/1927367/Polaris_logo_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.